當前位置：首頁 SCI期刊 SCIE期刊醫(yī)學(xué) 中科院3區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Journal Of Thrombosis And ThrombolysisSCIE

國際簡稱：J THROMB THROMBOLYS 參考譯名：血栓形成和溶栓雜志

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：0929-5305; E-ISSN：1573-742X; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：NETHERLANDS; 出版商：Springer US; 出版語言：English; 出版周期：Bimonthly; 出版年份：1994; 研究方向：醫(yī)學(xué)-外周血管病

評價信息：: 影響因子：2.3; H-index：59; CiteScore指數(shù)：9.2; SJR指數(shù)：0.744; SNIP指數(shù)：0.801

發(fā)文數(shù)據(jù)：: Gold OA文章占比：24.71%; 研究類文章占比：90.60%; 年發(fā)文量：149; 自引率：0; 開源占比：0.1446; 出版撤稿占比：0; 出版國人文章占比：0.09; OA被引用占比：0.1100...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Journal Of Thrombosis And Thrombolysis期刊介紹

The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.

The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.

期刊簡介Journal Of Thrombosis And Thrombolysis期刊介紹

《Journal Of Thrombosis And Thrombolysis》自1994出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學(xué)領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關(guān)注點：

預(yù)計審稿時間：偏慢,4-8周
醫(yī)學(xué)
HEMATOLOGY
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Journal Of Thrombosis And Thrombolysis Cite Score數(shù)據(jù)

CiteScore：9.2
SJR：0.744
SNIP：0.801

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Cardiology and Cardiovascular Medicine	Q1	53 / 387	86%
大類：Medicine 小類：Hematology	Q1	22 / 137	84%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Journal Of Thrombosis And Thrombolysis 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	HEMATOLOGY 血液學(xué) CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) PERIPHERAL VASCULAR DISEASE 外周血管病	3區(qū) 4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Journal Of Thrombosis And Thrombolysis JCR分區(qū)

2023-2024 年最新版

按JIF指標學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	103 / 220	53.4%
學(xué)科：HEMATOLOGY	SCIE	Q2	48 / 97	51%
學(xué)科：PERIPHERAL VASCULAR DISEASE	SCIE	Q2	44 / 96	54.7%

按JCI指標學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	67 / 220	69.77%
學(xué)科：HEMATOLOGY	SCIE	Q2	29 / 97	70.62%
學(xué)科：PERIPHERAL VASCULAR DISEASE	SCIE	Q1	24 / 96	75.52%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻質(zhì)量進行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
USA364
Italy98
CHINA MAINLAND97
GERMANY (FED REP GER)50
Japan44
England38
Canada36
France28
Australia24
Israel21

本刊中國學(xué)者近年發(fā)表論文

1、Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest
Author: Guan, Xinliang; Li, Lei; Lu, Xuran; Gong, Ming; Li, Haiyang; Liu, Yuyong; Jiang, Wenjian; Lan, Feng; Wang, Xiaolong; Zhang, Hongjia

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 67-73. DOI: 10.1007/s11239-022-02706-5
2、Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry
Author: Sun, Dapeng; Raynald; Huo, Xiaochuan; Jia, Baixue; Tong, Xu; Ma, Gaoting; Wang, Anxin; Ma, Ning; Gao, Feng; Mo, Dapeng; Miao, Zhongrong

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 1-8. DOI: 10.1007/s11239-022-02712-7
3、Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions
Author: Zhang, Fan; Cao, Xudong; Zhao, Chunhui; Chen, Li; Chen, Xiaolin

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 116-125. DOI: 10.1007/s11239-022-02719-0
4、Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis
Author: Zheng, Xiaojie; Gao, Fangbo; Wang, Le; Meng, Yao; Ageno, Walter; Qi, Xingshun

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 18-31. DOI: 10.1007/s11239-022-02732-3
5、Role of cerebral microbleeds in acute ischemic stroke and atrial fibrillation
Author: Wang, Meng; Yang, Yuyuan; Luan, Moxin; Wang, Yajuan; Zhong, Meixiang; Xu, Lulu; Zheng, Xueping

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 3, pp. 553-565. DOI: 10.1007/s11239-022-02761-y
6、Causal relationship between moderate to vigorous physical activity and venous thromboembolism
Author: Hu, Mengjin; Wang, Xiaoning; Yang, Yuejin

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 3, pp. 576-583. DOI: 10.1007/s11239-022-02754-x
7、Age at smoking initiation and smoking cessation influence the incidence of stroke in China: a 10-year follow-up study
Author: Liang, Tian; Xie, Changping; Lv, Bangjun; Su, Li; Long, Jianxiong; Liu, Shengying; Huang, Xiaolan; Pei, Pei; Pan, Rong; Lan, Jian

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11239-023-02812-y
8、Angiojet pharmacomechanical thrombectomy versus anticoagulant therapy alone in massive cancer-associated thrombosis: a single centre retrospective cohort study
Author: Gong, Maofeng; Fu, Guanqi; Liu, Zhengli; Zhao, Boxiang; Kong, Jie; He, Xu; Gu, Jianping

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 2, pp. 365-375. DOI: 10.1007/s11239-023-02770-5